Central Plains Bancshares, Inc. Common Stock

NASDAQ:CPBI

Shell Companies

Financial Services
$20.51 -0.96%

-$0.18 today

Market cap
$85.57M
Beta
0.21
P/E (TTM)
18.0
EPS (TTM)
$1.03
52W Low $14.85High $18.75

Volume 0.00M

Average 0.00M

CPBI Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Central Plains Bancshares, Inc. Common StockNASDAQ: CPBI

Research & Development · Q3 FY2025 · quarter ended Dec 2025

Research & development remains negative

Q3 FY2025 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2024, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2024 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearMar 2025
$0— YoY
LTMDec 2025
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2024
0 USD
Year-over-year change
—

Research & Development vs competitors

How CPBI compares with its peers on the latest reported figures

  • CPBI's LTM Dec 2025 research & development of $0 is the highest of the 8 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for CPBI, versus a peer median of 0.0%.
CPBI Competitors Peer median
Research & Development for CPBI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CPBICentral Plains Bancshares, Inc. Common StockLTM Dec 2025$0 ——0.0%
BOTJBank of the James Financial Group, Inc.LTM Mar 2026$0 ——0.0%
FUSBFirst US Bancshares, Inc.LTM Mar 2026$0 ——0.0%
IORIncome Opportunity Realty Investors, Inc.LTM Mar 2026$0 ——0.0%
ORIQUOrigin Investment Corp I UnitsLTM Mar 2026$0 ———
RIBBRibbon Acquisition CorpLTM Mar 2026$0 ———
AFJKAimei Health Technology Co., LtdLTM Mar 2026$0 ———
BAYABayview Acquisition Corp Class A Ordinary SharesLTM Mar 2026$0 ———
Peer median (excluding CPBI) $0——0.0%

Competitors are the stored peer set for CPBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
Revenue15.68M18.42M23.82M27.31M
Cost of Revenue965K5.62M6.58M8.41M
Gross Profit14.71M12.8M17.24M18.9M
Gross Margin93.8%69.5%72.4%69.2%
Research & Development0000
Selling, General & Admin6.65M6.18M7.47M8.49M
Operating Expenses10.97M10.84M12.6M14.38M
Depreciation & Amortization497K503K518K455K
EBITDA4.24M2.47M5.15M4.98M
EBITDA Margin27.0%13.4%21.6%18.2%
Operating Income3.74M1.96M4.64M4.52M
Operating Margin23.9%10.7%19.5%16.6%
Interest Income13.17M16.14M20.96M24.7M
Interest Expense1.08M2.74M6.49M8.21M
Other Income / Expenses0000
Income Before Tax3.74M1.96M4.64M4.52M
Pre-Tax Margin23.9%10.7%19.5%16.6%
Income Tax Expense595K317K877K869K
Net Income3.15M1.65M3.76M3.65M
Net Margin20.1%8.9%15.8%13.4%
EPS (Basic)0.860.451.100.96
EPS (Diluted)0.860.401.100.96
Weighted Avg Shares3.68M3.68M3.44M3.82M
Weighted Avg Shares (Diluted)3.68M4.13M3.44M3.82M

Central Plains Bancshares, Inc. Common Stock

NASDAQ:CPBI

Intrinsic Alpha fair value

Locked

Current Price

$20.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.